← Back to Search

Health Communication for HIV/AIDS and Hepatitis C

N/A

Recruiting

Led By Roland C Merchant, MD

Research Sponsored by Icahn School of Medicine at Mount Sinai

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up end of study, at 5 years

Awards & highlights

Study Summary

This trial will assess how a brief persuasive health communication intervention can increase HIV/HCV screening acceptance among ED patients who initially declined. It will compare two delivery forms of this intervention, by a video or HIV/HCV counselor, and assess its efficacy among different injection-drug use history cohorts.

Who is the study for?

This trial is for adults over 18 who speak English or Spanish, have not been tested for HIV/HCV in the past year, and are not currently infected with or being treated for these viruses. It's aimed at those who initially declined testing in the emergency department.Check my eligibility

What is being tested?

The study tests a persuasive health communication intervention to increase acceptance of HIV/HCV screening. Participants will be randomly assigned to receive this intervention either through a video or directly from an HIV/HCV counselor.See study design

What are the potential side effects?

Since the interventions involve educational content delivered by video or counselor without medical procedures, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ end of study, at 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~end of study, at 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study, at 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of patients who accept HIV/HCV testing after speaking with a health educator

Number of patients who accept HIV/HCV testing after watching the video

Secondary outcome measures

Health economics assessment of PHCI

The number of patients that accept HIV/HCV testing by current injection-drug use

The number of patients that accept HIV/HCV testing by former injection-drug use

+1 more

Trial Design

2Treatment groups

Active Control

Group I: Persuasive Health Communication Intervention delivered by Health EducatorActive Control1 Intervention

Healthcare provider educator getting patients screened for HIV/HCV.

Group II: Persuasive Health Communication Intervention delivered in video formatActive Control1 Intervention

A video created by the research team will be played to persuade patients to participate in HIV and Hepatitis C (HCV) screening.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor

862 Previous Clinical Trials

523,626 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,617,731 Total Patients Enrolled

Roland C Merchant, MDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai

2 Previous Clinical Trials

1,625 Total Patients Enrolled

Media Library

Persuasive Health Communication Intervention delivered by Health Educator Clinical Trial Eligibility Overview. Trial Name: NCT05968573 — N/A

HIV/AIDS Research Study Groups: Persuasive Health Communication Intervention delivered by Health Educator, Persuasive Health Communication Intervention delivered in video format

HIV/AIDS Clinical Trial 2023: Persuasive Health Communication Intervention delivered by Health Educator Highlights & Side Effects. Trial Name: NCT05968573 — N/A

Persuasive Health Communication Intervention delivered by Health Educator 2023 Treatment Timeline for Medical Study. Trial Name: NCT05968573 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has this clinical experiment commenced recruitment?

"According to clinicaltrials.gov, this medical trial is currently not open for recruitment; the initial post-date was September 1st 2023 and it was last updated on July 21st of the same year. Despite this study being closed to new participants, there are 692 other research programs that are still recruiting patients."

Answered by AI

Can you explain the primary goals of this research endeavor?

"The primary measured outcome of this trial is the number of patients who accept HIV/HCV testing after engaging with a health educator, over a period stretching from Day 1 to 5 minutes post-intervention. Secondary outcomes considered include the acceptance rate for HIV/HCV tests by former and current injection drug users, as well as an economic evaluation of cost versus effectiveness in persuading real world populations to test for these viruses."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Persuasive Health Communication Intervention for HIV/HCV

Roland Merchant 2024. "Persuasive Health Communication Intervention for HIV/HCV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05968573.

All > Hepatitis C